2013 American Transplant Congress
Clinical Significance of Protocol Biopsy at Three Months after Kidney Transplantation: A Single Center Experience
The aim of this study was to analyze the characteristics of subclinical acute rejection and borderline change in protocol biopsies performed 3 months after kidney…2013 American Transplant Congress
Neighborhood-Level Factors Associated with Low Kidney Transplant Rates among U.S. Dialysis Facilities
Background: Variability in kidney transplant rates across U.S. dialysis units has been noted, yet little is known of the association of neighborhood-level factors around dialysis…2013 American Transplant Congress
Potential Downfall of Failed Prednisone Wean after Heart Transplant
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: A prednisone taper off protocol is often initiated in heart transplant recipients 6 months post transplant to avoid the long-term adverse effects of steroid…2013 American Transplant Congress
Distribution of Skin Cancers and Precancerous Lesions among Transplant Patients Based on Fitzpatrick Skin Type
Drexel Medicine University of Medicine, Philadelphia, PA
Background: Fitzpatrick Skin Type is a classification system used by dermatologists to categorize the response of different skin types to ultraviolet light and to assess…2013 American Transplant Congress
Axin2/β-Catenin/Notch1 Sigaling Regulates Innate Immunity in Mouse Model of Liver Ischemia/Reperfusion Injury
Dumont-UCLA Transplant Ctr, Dept of Surgery, UCLA School of Medicine, Los Angeles, CA
Background: Axin2 is a multiple function protein involved in many biological pathways, and its overexpression might regulate Β-catenin activity. The Notch signaling is known to…2013 American Transplant Congress
Preliminary Experience Utilizing Boceprevir with Pegylated Interferon and Ribavirin for Treatment of Recurrent Hepatitis C Genotype 1 after Liver Transplantation
Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix
Background Hepatitis C virus (HCV) recurrence after liver transplant is universal and causes significant reduction in both graft and patient survival. The use of protease…2013 American Transplant Congress
Impact of Changing Patterns in Deceased Donor Cause of Death on Organs Transplanted Per Donor
United Network for Organ Sharing, Richmond, VA
Background: The distribution of donor cause of death (DCOD) has changed substantially over the last decade. This analysis was performed to assess geographic variability and…2013 American Transplant Congress
Impact of De Novo IgG3 DSA in Graft Survival after Liver Transplantation
Aim: To evaluate if the presence of de novo IgG3 subclass donor-specific HLA antibodies (DSA) help to identify patients at risk of graft loss after…2013 American Transplant Congress
Association between the CYP3A5*1 Allele, Tacrolimus Concentrations and Renal Function in Lung Transplant Recipients
Dose-adjusted tacrolimus (TAC) trough levels (ng/ml per mg/day, L/D) are significantly lower in lung transplant recipients (LTxR) who are CYP3A5 expressors (*1/*1 or *1/*3) versus…2013 American Transplant Congress
Tacrolimus-Induced Diabetes Compared to Cyclosporine May Lead to More Diabetic Complications Post Heart Transplant
Cedars-Sinai Heart Institute, Los Angeles, CA
BACKGROUND: Cyclosporine (CSA) and tacrolimus (TAC) are the main immunosuppressive agents in heart transplantation. Both CSA and TAC are diabetogenic, however, in clinical practice, TAC…
American Transplant Congress abstracts